Deutsche Bank
ROSG

Deutsche Bank’s Rosetta Genomics Ltd. ROSG Stock Holding History

Deutsche Bank’s Portfolio ROSG Stock Details ROSG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2
Closed – – 5835
2017
Q4 		$0 Hold
2
– – ﹤0.01% 5351
2017
Q3 		$0 Buy
+2
New +$4 ﹤0.01% 5332
2017
Q1 		– Hold
0
– – – 5286
2016
Q4 		– Hold
0
– – – 5224
2016
Q3 		– Hold
0
– – – 5441
2016
Q2 		– Hold
0
– – – 5494

Other funds holding ROSG

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HCM
Highlander Capital Management Short Hills, New Jersey $292M AUM 22.24% 1-Year Est. Return

Deutsche Bank's ROSG Position: Q1 2018 in Review

Deutsche Bank sold out of Rosetta Genomics Ltd. (ROSG) in Q1 2018, closing a stake of 2 shares.

Deutsche Bank first reported a position in ROSG in Q3 2017 and held it in 2 quarters. The position peaked at $0 in Q4 2017. 8 funds tracked by Wall St. Rank hold ROSG as of Q1 2018.

  • Deutsche Bank reported no remaining Rosetta Genomics Ltd. position as of Q1 2018 after selling out during the quarter.
  • Deutsche Bank sold 2 Rosetta Genomics Ltd. shares in Q1 2018.
  • Deutsche Bank first reported a position in Rosetta Genomics Ltd. in Q3 2017 and held it in 2 quarters.
  • Deutsche Bank's Rosetta Genomics Ltd. position peaked at $0 in Q4 2017.
  • 8 funds tracked by Wall St. Rank held Rosetta Genomics Ltd. as of Q1 2018.

Based on Deutsche Bank's 13F filing for Q1 2018, filed 15 May 2018.